Noveome Biotherapeutics, formerly Stemnion
13 clinical trials · Sponsor
◉ Watch Noveome Biotherapeutics, formerly Stemnion
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC) (NCT06315738) | Noveome Biotherapeutics, formerly Stemnion | 2024-08-19 |
| ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects (NCT05066698) | Noveome Biotherapeutics, formerly Stemnion | 2022-04-27 |
| Safety and Tolerability Study of IV ST266 in COVID-19 Subjects (NCT04720378) | Noveome Biotherapeutics, formerly Stemnion | 2021-05-30 |
| Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects (NCT03901781) | Noveome Biotherapeutics, formerly Stemnion | 2019-10-23 |
Track Noveome Biotherapeutics, formerly Stemnion automatically
Every clearance here is in the API, with alerts when new ones post.